Extended HPV genotyping assay with enhanced detection of E6/E7 markers. Provides comprehensive HPV type identification for cervical cancer screening.
Manufactured by
Suzhou, Jiangsu, China
In 2007, GenDxbio was founded, which marked the company's initial stage. In 2017, GenDx Biotech was established and acquired GenDxbio in the same year. GenDx Biotech is committed to on-spot pathogens detection solutions with the molecular Point-of-Care Testing (POCT) technology platforms and the comprehensive instrument systems. Over the past two decades, ERA Technology (Enzymatic Rapid Amplification) and GENEYE ® systems developed by GenDx Biotech have been highly recongnized as a preferred solution for various pathogens identification in kinds of scenarios.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 10 relevant products
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Attogen Biomedical(Suzhou)Ltd.Inc
China · 14 relevant products
shanghai rendu biotechnology co.,ltd.
China · 1 relevant product
APPOLON BIOTECK SAS
France · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
SeeGene Middle East FZE
South Korea · 3 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 5 relevant products
Hangzhou DALTON BioSciences, Ltd.
China · 4 relevant products
Advanced Molecular Diagnostics Ltd.
United Kingdom · 4 relevant products
34 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 99 closest product alternatives
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
HPV genotyping assay detecting 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82 high-risk variants for comprehensive cervical cancer risk assessment.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Proprietary E7 antibody-based immunocytochemistry assay for cervical intraepithelial neoplasia detection. Enables immunochemical staining and identification of tissue samples using monoclonal antibody markers. Designed for cervical screening and tissue characterization.
shanghai rendu biotechnology co.,ltd. · China
The AmpSure® HPV 16/18 Genotype Assay is an in vitro diagnostic test for detecting and genotyping human papillomavirus (HPV) types 16 and 18 in clinical specimens. This molecular assay enables precise identification of high-risk HPV strains associated with cervical cancer and related malignancies, supporting clinical screening and risk stratification protocols.
APPOLON BIOTECK SAS · France
A molecular diagnostic test kit for HPV screening recommended by the CNR Papillomavirus for cervical cancer detection. The test has been validated through rigorous clinical studies demonstrating sensitivity, specificity, and compliance with international standards.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Multi-marker panel assay for HPV-related cervical disease detection. Includes E7 and E6 antibody-based detection methods for comprehensive HPV screening. Designed for pathological assessment of cervical tissue samples.
guangzhou biotron technolongy co.,ltd · China
An HPV E6/E7 mRNA genotyping detection assay that provides risk stratification for cervical lesions. It reduces unnecessary colposcopy referrals while improving the detection rate of CIN2+ lesions and enabling more precise clinical management.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.
SeeGene Middle East FZE · South Korea
The Allplex HPV28 Assay is a real-time PCR-based diagnostic test that simultaneously detects 28 human papillomavirus (HPV) types for cervical cancer screening and risk stratification. This high-multiplex assay integrates seamlessly into automated laboratory workflows, enabling rapid syndromic detection with comprehensive HPV genotyping in a single reaction.
HLB PANAGENE Co., Ltd. · South Korea
A comprehensive HPV genotyping assay for detection and identification of human papillomavirus types in cervical and other samples.
Hangzhou DALTON BioSciences, Ltd. · China
Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.
87 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products